There is a continued interest in the properties of arsenic thiolate compounds for both industrial and biological uses. Recent discoveries in the medicinal properties of such compounds have resulted in a sustained need for the synthesis of new dithiarsolane compounds for research as anti-leukemic compounds. Close analogues of the 2-halo arsenic dithiolates, namely those with an arsenic-carbon bond instead of an arsenic-halide bond, have recently been shown to have some efficacy towards leukemia cells. Based on the hydrolytic character and the active role of glutathione with arsenic in vivo, the compounds reported here may also have such activity. Arsenic compounds have demonstrated biological activity in the literature, thus the hypothesis of this thesis is cyclized arsenic thiolates can be synthesized with the appropriate characteristics as to be potentially useful medicinal agents as well as provide new structural and reaction information. A series of arsenic and antimony di- and trithiolates has been synthesized and characterized. Those compounds include 2-chloro-1,3,2-dithiarsolane, 2-bromo- 1,3,2-dithiarsolane, 2-iodo-1,3,2-dithiarsolane, 2-chloro-1,3,2-dithiarsenane, 2-bromo- 1,3,2-dithiarsenane, 2-iodo-1,3,2-dithiarsenane, 3-chloro-4H,7H-5,6-benz-1,3,2- dithiarsepine, 2-chloro-benzo-1,3,2-dithiarsole, 1,2-bis-dithiarsolan-2-ylmercapto-ethane, tris-(pentafluorophenylthio)-arsen, bis(2-(1,3,2-benzodithiarsol-2ylsulfanyl)- benzenesulfide), 2-chloro-benzo-1,3,2-dithiastibole, and bis(2-(1,3,2-benzodithistibol)- 1,2-benzenedithiol. Elucidation of the pH characteristics of arsenic dithiolates within the human toxicity reaction pathway is an area of interest. It has been shown that the aqueous arsenic dithiolate stability depends on the size of the ring. 2-Chloro-1,3,2-dithiarsolane has been shown to be somewhat stable at both low and high pH as well as neutral pH. 1,2-bis- Dithiarsolan-2-ylmercapto-ethane is completely stable in a neutral aqueous solution. Glutathione does not permanently bind to arsenic even in overwhelming excess. In particular, these fully characterized compounds determine how reactive the AsS and AsCl linkages are under environmental and biological conditions, and provide a source of new reagents to examine in medical applications. Future applications may include the incorporation of the reported compounds in filtration and remediation technologies with further modification.

No description available.

The reaction of [MCl2(cod)] (M = Pt, Pd) with two equivalents of 2-(diphenylphosphinoamino)pyridine, Ph2PNHpy, in warm acetonitrile led to cationic complexes of the type cis-[MCl(Ph2PNHpy-P,N){Ph2PNHpy-P}][Cl] (M = Pt, Pd) which exhibit broad single 31P{1H} NMR resonances due to their dynamic pyridyl exchange behaviour in solution. A single crystal X-ray diffraction study of the platinum species confirmed the proposed structure and revealed that adjacent complex molecules were held together by hydrogen bonding to the same chloride counter-ion. The bromo- and iodo-cis[MX(Ph2PNHpy-P,N){Ph2PNHpy-P}][X] (M = Pt, Pd; X = Br, I) complexes were obtained by metathesis from the corresponding chloride complex.

The dinuclear cyclometallated gold(I) complex [Au2(μ-2-C6F4PPh2)2] was prepared in high yield from the reaction of 2-LiC6F4PPh2 with either [AuBr(AsPh3)] or [AuCl(tht)], and from the reaction of 2-Me3SnC6F4PPh2 with [AuCl(tht)]. The digold(I) complex undergoes oxidative addition reactions with halogens to give the metal-metal bonded dihalodigold(II) complexes [Au2IIX2(μ-2-C6F4PPh2)2] (X = Cl, Br, I), which on warming or exposure to light, isomerise to give the heterovalent gold(I)-gold(III) species [XAu(µ-2-C6F4PPh2)(κ2-2-C6F4PPh2)AuX] containing a four-membered cyclometallated ring on a gold(III) centre. Unlike its protio analogue, [Au2(μ-2-C6F4PPh2)2] did not undergo oxidative addition of methyl iodide or dibenzoyl peroxide. The dihalodigold(II) [Au2IIX2(μ-2-C6F4PPh2)2] and gold(I)-gold(III) compounds [XAu(µ-2-C6F4PPh2)(κ2-2-C6F4PPh2)AuX] (X = Cl, Br) are further oxidised by halogens to give the digold(III) species [Au2X4(μ-2-C6F4PPh2)2] and [X3Au(μ-2-C6F4PPh2)(κ2-2-C6F4PPh2)AuX], respectively. The complexes [Au2X4(μ-2-C6F4PPh2)2] are reduced to the dihalodigold(II) complexes in the presence of one equivalent of zinc powder; further addition of zinc gave the parent digold(I) dimer. Treatment of [Au2IICl2(μ-2-C6F4PPh2)2] and [ClAu(µ-2-C6F4PPh2)(κ2-2-C6F4PPh2)AuCl] with an excess of silver nitrate, benzoate, acetate, trifluoroacetate or triflate gave the corresponding oxyanion complexes. Slow crystallisation of the di(benzoato)digold(II) complex from dichloromethane and methanol gave the parent digold(I) complex derived by reductive elimination. The di(triflato)digold(II) complex behaved similarly, although in this case the novel gold(I) tetramer [Au4(μ-2-C6F4PPh2)4] was formed together with the dimer. Two closely related gold complexes containing the chelating κ2(C,O) phosphine oxide ligand, 2-C6F4P(O)PPh2, were isolated from the reaction of [ClAu(µ-2-C6F4PPh2)(κ2-2-C6F4PPh2)AuCl] with an excess of silver nitrate. The reaction of [Au2IICl2(μ-2-C6F4PPh2)2] with two equivalents of potassium trifluoroethoxide failed to give the corresponding digold(II) bis(alkoxo) complex; instead, reduction took place to form the digold(I) dimer [Au2(μ-2-C6F4PPh2)2]. Treatment of a solution of the di(benzoato)digold(II) complex with C6F5Li gave the pentafluorophenyl complex [Au2(C6F5)2(μ-2-C6F4PPh2)2] which, when heated in toluene, rearranged to the gold(I)-gold(III) complex [(C6F5)Au(µ-2-C6F4PPh2)(κ2-2-C6F4PPh2)Au(C6F5)], analogous to the behaviour of the dihalodigold(II) complexes. The heterovalent, gold(I)-gold(III) dimethyl compound [Au2I,III(CH3)2(μ-2-C6F4PPh2)2] was obtained from the reaction of the di(benzoato)digold(II) complex with dimethylzinc. This compound is structurally similar to its tetraprotio analogue. The cycloaurated dinuclear gold complexes [Au2(μ-C6H3-n-F-2-PPh2)2] (n = 5, 6) were made similarly to the 2-C6F4PPh2 analogue from the appropriate lithium or tin reagents, though in some cases the dimers were formed in admixture with the corresponding gold(I) tetramers. Like their tetrafluoro analogues, the 6-fluoro complexes [Au2X2(μ-C6H3-6-F-2-PPh2)2] (X = Cl, Br, I) rearrange on heating to give the heterovalent gold(I)-gold(III) species [XAu(µ-C6H3-6-F-2-PPh2)(κ2-C6H3-6-F-2-PPh2)AuX]. Thus, the presence of a fluorine atom in place of hydrogen in the 6-position of the bridging aryl group is sufficient to stop the isomerisation of the digold(II) complexes [Au2X2(μ-2-C6H4PPh2)2] at the gold(I)-gold(III) stage and to prevent subsequent C-C coupling of the aryl groups at the gold(III) centre. In contrast, the dihalodigold(II) complexes containing the 5-fluoro substituted ligand undergo reductive elimination and coupling of the metallated aryl groups to give the digold(I) biphenyldiyl complexes [Au2X2(2,2'-Ph2P-5-FC6H3C6H3-5-F-PPh2)] (X = Cl, Br, I). The described complexes were characterised using 1H NMR, 31P NMR, 19F NMR spectroscopy, elemental analysis, mass spectroscopy, IR spectroscopy, X-ray diffraction and 197Au Mössbauer spectroscopy.

No description available.

Photocrystallography is a relatively new and continuously developing technique used in the structure determination of metastable and transient species in the crystalline state. This thesis contains a description of investigations into photo-induced linkage isomerism reactions in the solid state with the use of single crystal and powder X-ray diffraction experiments to monitor structural changes at low temperature.

In this study, the aim was identification and classification of the enzyme having phenol oxidase activity produced by a thermophilic fungus, Scytalidium thermophilum. For this purpose, enzyme production, purification, biochemical characterization and structural analysis by X-ray crystallography studies have been performed. At the beginning of the research, this enzyme was considered as a phenol oxidase and analyzed accordingly. However, during purification, amino acid sequencing and structural studies, the enzyme was shown to be a catalase, with an additional catechol oxidase activity. This novel bifunctional catalase-catechol oxidase (CCO) was purified 10 fold with 45 % yield by anion exchange and gel filtration chromatographies. CCO was determined as a tetrameric protein having total and subunit molecular weights of 320 and 80 kDa, respectively. Isoelectric point of CCO was verified as 5.0. CCO catalase and catechol oxidase activities were characterized in terms of their kinetic behavior at different pH and temperatures. Depending on the substrate specificity and inhibitor studies of CCO, the phenol oxidase activity was determined as catechol oxidase but not tyrosinase or laccase. The best crystallization condition for CCO was determined and X-ray diffraction data was collected at the Daresbury Synchrotron Radiation Source (United Kingdom) at 2.7 &Aring / resolution. The preliminary structure was solved by molecular replacement method using Penicilium vitale catalase structure. CCO was verified to have a tetrameric structure with two homodimers and a metal center in each polypeptide chain.

La résistance antimicrobienne est devenue un problème majeur de santé publique. L’usage parfois abusif d’antibiotiques conduit à la sélection et à la propagation mondiale de mécanismes de résistance. Grâce à leur efficacité clinique et faible toxicité, les β-lactamines sont les antibiotiques les plus prescrits actuellement, et le mécanisme de résistance le plus répandu est l’expression de β-lactamases. Dans ces conditions, le développement de nouveaux traitements antimicrobiens, pour des cibles connues ou nouvelles, est essentiel. Plus particulièrement, le développement de nouveaux inhibiteurs des β-lactamases est très prometteur, permettant de continuer l’utilisation des antibiotiques existants. Les études biochimiques et structurales des nouvelles β-lactamases et leurs mutants synthétiques, par cristallographie aux rayons X ou par différentes techniques de modélisation moléculaire (modélisation par homologie, « docking », dynamique moléculaire, analyse du réseau des molécules d’eau) permettent une meilleure compréhension de ces enzymes. Dans ce contexte, nous avons caractérisé plusieurs β-lactamases du point de vue phénotypique, biochimique et structural.La β-lactamase CMY-136 contient une mutation inhabituelle, Y221H, par rapport à CMY-2, dans une position qui est très conservée parmi les enzymes de classe C. Les études cristallographiques et de modélisation moléculaire ont révélé des interactions stériques défavorables autour de la position mutée 221 qui peuvent affecter la conformation et la dynamique de la boucle Ω, et qui pourraient expliquer l’hydrolyse plus efficace des substrats volumineux et l’affinité plus faible de la plupart des substrats par rapport à la CMY-2.La structure cristallographique de la β-lactamase OXA-427, une nouvelle carbapénèmase de classe D, montre une Lys73 très peu carbamoylée, ce qui est très inhabituel pour cette classe d’enzyme, ainsi qu’un pont hydrophobe à proximité du site actif. Les simulations de dynamique moléculaire ont montré que la boucle β5-β6 est plus flexible et dans une conformation étendue. Ces résultats peuvent expliquer le profil d’hydrolyse unique observé expérimentalement pour cette enzyme.Les modifications dans la boucle β5-β6 de la β-lactamase OXA-48 (mutations d’alanines, délétions systematiques, remplacement par la boucle β5-β6 de la β-lactamase OXA-18) provoquent des modifications importantes dans le profil d’hydrolyse, avec une acquisition graduelle d’une activité cephalosporinase et une diminution de l’activité carbapénémase dans certains cas. Des études de cristallographie aux rayons X et modélisation moléculaire suggèrent que les différences de conformation et de flexibilité dans cette boucle et les régions adjacentes permettent une meilleure fixation des céphalosporines plus volumineuses, par rapport à l’OXA-48. L’analyse de la dynamique des molécules d’eau dans le site actif montre des changements qui sont potentiellement responsables de la diminution de l’activité par rapport aux carbapénèmes. En complément des études sur les mutants naturels, ces résultats confirment l’importance de la boucle β5-β6 pour la spécificité de substrat des enzymes de type OXA-48. La structure cristallographique du mutant 217ΔP de l’OXA-48 présente une conformation auto-inhibée inattendue, induite par la présence d’un ion nitrate, un inhibiteur auparavant inconnu des β-lactamases de classe D.La Beta-Lactamase DataBase(BLDB, http://bldb.eu) développée dans notre équipe est une ressource publique exhaustive contenant des données relatives aux β-lactamases, vérifiées et mises à jour régulièrement. Cette base de données contient tous les mutants naturels et synthétiques de β-lactamases, ainsi que toutes les structures 3D disponibles dans la PDB et la caractérisation phénotypique.Globalement, ces résultats représentent le prérequis pour une meilleure compréhension des relations structure-fonction des β-lactamases et pour le futur développement rationnel d’inhibiteurs pour ces enzymes. / Antimicrobial resistance (AMR) has become a major threat to public health nowadays. The use and abuse of antibiotics is increasingly leading to selection and spread of resistance mechanisms worldwide, greatly compromising our capacity to treat infectious diseases. AMR might ultimately result in a future without effective antimicrobial therapy. Due to their safety and clinical efficacy, β-lactams are the most utilized antimicrobial therapy, and the most common resistance mechanism is the expression of β-lactamases. Therefore, the development of new antimicrobial drugs, for novel or already known targets, is of utmost importance. In particular, the development of novel inhibitors towards β-lactamases is also quite promising, as it would allow us to continue using the effective and safe antimicrobial drugs already available today. The biochemical and structural study of novel β-lactamases or synthetic mutants, through X-ray crystallography and various molecular modelling techniques (homology modelling, docking, molecular dynamics, water network analysis), can provide valuable information. In this context, we have characterized phenotypically, biochemically and structurally several β-lactamases.The CMY-136 β-lactamase possesses an unusual mutation, Y221H, as compared to CMY-2, in a position highly conserved among class C ß-lactamases. Crystallographic and molecular modelling experiments reveal a steric impediment around the mutated position 221 that may affect the conformation and dynamics of the Ω-loop, and therefore account for an increased turnover rate for bulky substrates and a decreased affinity for most substrates as compared to CMY-2.The crystal structure of the OXA-427, a novel class D carbapenemase, shows the Lys73 only partially carbamoylated, a very unusual characteristic for this class of β-lactamases, and an unexpected hydrophobic bridge in the vicinity of the active site. Moreover, molecular dynamics simulations revealed an extended and highly flexible β5-β6 loop. Altogether, these features may explain the unique hydrolytic profile determined experimentally for this enzyme.Modifications in the β5-β6 loop of the OXA-48 β-lactamase (alanine scanning, systematic deletions, replacement with the β5-β6 loop from OXA-18) result in profound changes in the hydrolytic profile, with gradual acquisition of cephalosporinase activity and decrease of carbapenemase activity in some cases. X-ray crystallography and molecular modelling studies suggest that the altered conformation and flexibility of this loop and of adjacent regions in these mutants may allow for the better accommodation of the bulkier cephalosporins, compared to OXA-48. Additionally, water dynamics analysis highlighted changes in the water network around and inside the active site cavity that may be responsible for the lower activity towards carbapenems. Together with studies on other naturally occurring mutants, results corroborate the relevance of the β5-β6 loop on the substrate profile of OXA-type enzymes. Crystal structure of the OXA-48 217ΔP mutant reveals an unexpected self-inhibited conformation induced by the presence of a nitrate ion, a previously unknown inhibitor of class D β-lactamases.Finally, the Beta-Lactamase DataBase (BLDB, http://bldb.eu) developed in our laboratory is a comprehensive, manually curated public resource providing up-to-date structural and functional information on β-lactamases. It contains all reported naturally-occurring β-lactamases and synthetic mutants, together with all available 3D structures from the PDB and the phenotypical characterization.Overall, these results constitute an essential foundation for a better understanding of the structure-function relationship of β-lactamases, which may prove crucial for the future rational development of β-lactamase inhibitors.

A series of dioxidomolybdenum(VI) complexes, [MoVIO2L1–6] (1–6) and [MoVIO2L1–6(solv)] (1a–6a) {where solv (solvent) = DMSO (1a, 3a, 5a and 6a) and H2O (2a and 4a)} have been synthesized using thiosemicarbazone ligands, H2L1–6. Furthermore, six monooxidomolybdenum(IV) complexes [MoIVOL1–6(N-N)] (7–12) {where co-ligand (N-N) = 2,2′-bipyridine (bipy) (7, 10 and 11) and 1,10-phenanthroline (phen) (8, 9 and 12)} have also been synthesized from the corresponding Mo(VI) precursors, [MoVIO2L1–6] (1–6) by oxygen atom transfer (OAT) reaction. Complexes have been characterized by conventional methods, including X-ray crystallography, and DFT (density functional theory) calculations. OAT reactivity of Mo(VI) and Mo(IV) complexes have been successfully established through the formation of OPPh3 and Me2S. These OAT products have been characterized by 31P NMR (OPPh3), UV–Vis spectroscopy and GC–MS (Me2S) and DFT simulations supported this finding through the prediction of ΔGtotsol for the reaction of oxygen atom transfer. DFT methods suggested that the oxygen atom transfer from [MoVIO2L] species to PPh3 to give [MoIVOL(bipy)] and from DMSO to [MoIVOL(bipy)] to yield [MoVIO2L] is strongly favored, whereas the formation of μ-oxido dimer [MoV2O3L2], is much less probable.

Re(hfac)₃ has been found to crystallize in a hexagonal unit cell but the detailed structure has not been completed because of disordering problems along the c axis. The two-dimensional structure of Re(hfac)₃ reveals C₃ symmetry and no distortion of the octahedron composed of the six Re-O bonds. Re(acac)₃ has been found to belong to the α-type isomorphous set designated by Astbury. From x-ray powder photographs, the structure of Re(acac)₃ has been demonstrated to have the same gross structural features as Mn(acac)₃ but is not necessarily isostructural. Arguments are presented to show that β-V(acac)₃ is representative of the β-modification and that the β-type isomorphous set crystallizes in a monoclinic unit cell with a β-angle of 90º. Rotational transitions between the three isomorphous sets have been examined and found to be energetically unfavourable. / Thesis / Master of Science (MSc)